These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26346889)

  • 21. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
    Kauf TL; Svatek RS; Amiel G; Beard TL; Chang SS; Fergany A; Karnes RJ; Koch M; O'Hara J; Lee CT; Sexton WJ; Slaton JW; Steinberg GD; Wilson SS; Techner L; Martin C; Moreno J; Kamat AM
    J Urol; 2014 Jun; 191(6):1721-7. PubMed ID: 24342144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
    Kraft MD
    Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.
    Hilton WM; Lotan Y; Parekh DJ; Basler JW; Svatek RS
    BJU Int; 2013 Jun; 111(7):1054-60. PubMed ID: 23171223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis.
    Xu LL; Zhou XQ; Yi PS; Zhang M; Li J; Xu MQ
    J Surg Res; 2016 Jun; 203(1):211-21. PubMed ID: 27338552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
    Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use.
    Senagore AJ; Bauer JJ; Du W; Techner L
    Surgery; 2007 Oct; 142(4):478-86. PubMed ID: 17950339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis.
    Ludwig K; Viscusi ER; Wolff BG; Delaney CP; Senagore A; Techner L
    World J Surg; 2010 Sep; 34(9):2185-90. PubMed ID: 20526599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database.
    Poston S; Broder MS; Gibbons MM; Maclaren R; Chang E; Vandepol CJ; Cook SF; Techner L
    P T; 2011 Apr; 36(4):209-20. PubMed ID: 21572777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis: Alvimopan vs. placebo in the treatment of post-operative ileus.
    Tan EK; Cornish J; Darzi AW; Tekkis PP
    Aliment Pharmacol Ther; 2007 Jan; 25(1):47-57. PubMed ID: 17042776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging pharmacologic options for treating postoperative ileus.
    Kraft MD
    Am J Health Syst Pharm; 2007 Oct; 64(20 Suppl 13):S13-20. PubMed ID: 17909271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of postoperative ileus: focus on alvimopan.
    Marderstein EL; Delaney CP
    Ther Clin Risk Manag; 2008 Oct; 4(5):965-73. PubMed ID: 19209278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxegol versus Alvimopan for Enhancing Postoperative Recovery following Radical Cystectomy for Bladder Cancer.
    Kirk PS; Wang A; Raskolnikov D; Psutka SP; Gore JL; Nyame YA; Kelly J; Wright JL
    Urol Pract; 2022 Sep; 9(5):364-370. PubMed ID: 37145718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
    Saclarides TJ
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
    Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
    Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alvimopan retains efficacy in patients undergoing colorectal surgery within an established ERAS program.
    Brown S; McLoughlin J; Russ A; Casillas M; Buehler J; Heidel RE; Yates JR
    Surg Endosc; 2022 Aug; 36(8):6129-6137. PubMed ID: 35043232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alvimopan as part of the Enhanced Recovery After Surgery protocol following radical cystectomy is associated with decreased hospital stay.
    Hanna P; Regmi S; Kalapara A; Mulpuri KS; Zabell J; Albersheim J; Wahr J; Randle D; Kaizer A; Patten L; Konety B; Weight C
    Int J Urol; 2021 Jun; 28(6):696-701. PubMed ID: 33769634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does alvimopan enhance return of bowel function in laparoscopic gastrointestinal surgery? A meta-analysis.
    Nguyen DL; Maithel S; Nguyen ET; Bechtold ML
    Ann Gastroenterol; 2015; 28(4):475-80. PubMed ID: 26423597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus.
    Maffezzini M; Campodonico F; Canepa G; Gerbi G; Parodi D
    Surg Oncol; 2008 Jul; 17(1):41-8. PubMed ID: 17962014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial.
    Baumgartner JM; Chen R; Messer K; Veerapong J; Kelly KJ; Ramamoorthy S; Lowy AM
    J Am Coll Surg; 2022 Nov; 235(5):693-701. PubMed ID: 36102565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Study of Patients Undergoing Radical Cystectomy and Receiving Peri-Operative Naloxegol or Alvimopan: Comparison of Length of Stay.
    Goodstein T; Launer B; White S; Lyon M; George N; DeRonde K; Burke M; O'Donnell C; Lyda C; Kiser TH; Wilson S
    J Surg (N Y N Y); 2018 Oct; 6(5):129-134. PubMed ID: 30574521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.